California Public Employees Retirement System purchased a new stake in shares of Cantel Medical Corp. (NYSE:CMD) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 69,600 shares of the company’s stock, valued at approximately $5,423,000. California Public Employees Retirement System owned 0.17% of Cantel Medical Corp. at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Capstone Asset Management Co. bought a new stake in shares of Cantel Medical Corp. in the second quarter worth approximately $690,000. Bank of Montreal Can bought a new stake in shares of Cantel Medical Corp. in the second quarter worth approximately $248,000. GW&K Investment Management LLC bought a new stake in shares of Cantel Medical Corp. in the second quarter worth approximately $30,121,000. Pennsylvania Trust Co bought a new stake in shares of Cantel Medical Corp. in the second quarter worth approximately $6,590,000. Finally, State of Alaska Department of Revenue bought a new stake in shares of Cantel Medical Corp. in the second quarter worth approximately $558,000. 83.82% of the stock is owned by institutional investors.
CMD has been the subject of several recent research reports. Sidoti upgraded shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 target price for the company in a research report on Wednesday, August 2nd. Zacks Investment Research upgraded shares of Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research report on Tuesday, August 1st. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a report on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $91.67.
Cantel Medical Corp. (NYSE CMD) traded up 1.70% during trading on Friday, hitting $97.46. 1,362 shares of the stock traded hands. Cantel Medical Corp. has a 52-week low of $68.19 and a 52-week high of $99.83. The stock has a 50 day moving average price of $91.13 and a 200-day moving average price of $79.60. The stock has a market cap of $4.05 billion, a P/E ratio of 56.99 and a beta of 1.25.
Cantel Medical Corp. (NYSE:CMD) last released its quarterly earnings data on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.02. The company had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. Cantel Medical Corp. had a return on equity of 17.60% and a net margin of 9.27%. Cantel Medical Corp.’s revenue for the quarter was up 14.8% on a year-over-year basis. On average, analysts anticipate that Cantel Medical Corp. will post $2.34 EPS for the current fiscal year.
In other news, Director Mark N. Diker sold 7,000 shares of the stock in a transaction dated Tuesday, October 3rd. The stock was sold at an average price of $98.90, for a total value of $692,300.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Eric W. Nodiff sold 2,868 shares of the stock in a transaction dated Friday, October 20th. The shares were sold at an average price of $97.55, for a total value of $279,773.40. Following the completion of the sale, the executive vice president now owns 39,102 shares of the company’s stock, valued at approximately $3,814,400.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,368 shares of company stock valued at $3,576,028. Insiders own 14.90% of the company’s stock.
WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/27/69600-shares-in-cantel-medical-corp-cmd-purchased-by-california-public-employees-retirement-system.html.
Cantel Medical Corp. Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.